Introduction
Brand name: Asfoxt Syrup
Manufacturer: Astemax Biotech Pvt. Ltd.
Pack size: 200 ml (syrup / suspension form – likely multi‑dose bottle; 200 ml pack is also listed in internal product sheet)
Composition (per 5 ml, as per Astemax‑type Ferrous Ascorbate + Folic Acid syrups)
Ferrous ascorbate 30 mg (providing elemental iron for haemoglobin synthesis)
Folic acid 550 mcg (for DNA synthesis and red‑cell formation)
Key indications
Asfoxt Syrup is an antianaemic and folate‑supporting nutritional syrup indicated in:
Iron‑deficiency anaemia (e.g., nutritional deficiency, chronic blood loss, pre‑operative and post‑surgical anaemia).
Folate‑deficiency anaemia and high‑folate‑demand states such as:
Pregnancy and lactation to support foetal neural‑tube development and maternal haematopoiesis.
Growth spurts, adolescence, and convalescence where iron and folate needs are elevated.
Key features
Ferrous ascorbate combines iron with vitamin C to improve absorption and reduce gastric irritation compared with other iron salts.
Folic acid corrects megaloblastic anaemia, supports erythropoiesis, and lowers neural‑tube defect risk when used per‑conception guidelines.
Syrup form with orange or sweet‑taste base improves palatability in children and compliance‑challenged adults.
Typical use and precautions
Dose is usually weight‑ and age‑based (e.g., 5–10 ml twice daily in children; once‑ or twice‑daily in adults), as per product‑specific insert and national‑anaemia‑control guidelines.
Astemax positions Asfoxt Syrup as a FSSAI‑oriented, iron‑and‑folate‑based antianaemic syrup suitable for paediatric‑care, obstetric, and general‑medicine setups managing nutritional and pregnancy‑related anaemias.
